Regulatory Science Extramural Research and Development Projects
Extramural Research Funded Through the Broad Agency Announcement (BAA)
To spur innovation in the field of regulatory science FDA funds extramural research using various contract mechanisms and grants to address broad Agency challenges within FDA's scientific priority areas.
Since 2012, FDA has been soliciting proposals to advance the state of the art within these areas through a specialized contract mechanism known as the Broad Agency Announcement (BAA). The BAA enables FDA to solicit innovative ideas and approaches to developing and evaluating our regulated products by tapping into external expertise and infrastructure in areas where FDA has limited expertise or capacities. The proposals solicited from industry, academia, and other government agencies enable FDA to better understand the breath of innovative scientific and technical solutions available to solve difficult regulatory science problems.